Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 7.20
+0.19 (2.71%)
Oct 27, 2026, 4:10 PM AEDT
Clinuvel Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Clinuvel Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $16.86. The average 1-year stock price forecast is 134.17% higher than the current stock price, while the lowest is $7.00 (-2.78%) and the highest is $39.30 (+445.83%).
Price Target: $16.86 (+134.17%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Clinuvel Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgans | Morgans | Hold Downgrades $10.00 → $7.00 | Hold | Downgrades | $10.00 → $7.00 | -2.78% | Oct 22, 2026 |
| Jefferies | Jefferies | Buy Maintains $40.80 → $39.30 | Buy | Maintains | $40.80 → $39.30 | +445.83% | Aug 31, 2026 |
| MA Financial Group | MA Financial Group | Buy Maintains $14.43 | Buy | Maintains | $14.43 | +100.42% | Aug 31, 2026 |
| Bell Potter | Bell Potter | Hold Downgrades $11.50 | Hold | Downgrades | $11.50 | +59.72% | Aug 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Downgrades $9.52 | Hold | Downgrades | $9.52 | +32.22% | Aug 27, 2026 |
Financial Forecast
Revenue This Year
94.47M
from 94.02M
Increased by 0.47%
Revenue Next Year
100.38M
from 94.47M
Increased by 6.25%
EPS This Year
0.68
from 0.67
Increased by 1.57%
EPS Next Year
0.70
from 0.68
Increased by 3.56%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.